| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.8M | -6.7% |
| Cost of Revenue | $6.5M | +3.0% |
| Gross Profit | $3.4M | -21.0% |
| R&D Expense | $17K | -86.7% |
| SG&A Expense | $7.2M | +75.1% |
| Operating Income | -$12.1M | -881.7% |
| Pre-tax Income | -$24.9M | -2728.5% |
| Income Tax | $17K | -63.8% |
| Net Income | -$24.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $143K | -24.7% |
| Accounts Receivable | $1.9M | +2.7% |
| Current Assets | $25.0M | +475.0% |
| Total Assets | $25.6M | +220.4% |
| Current Liabilities | $29.1M | +298.0% |
| Total Liabilities | $29.1M | +293.8% |
| Stockholders' Equity | -$3.5M | -775.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.5M | -443.9% |
| Capital Expenditures | $18K | +826.8% |
| Investing Cash Flow | -$268K | +24.7% |
| Financing Cash Flow | $2.5M | +1578.2% |
| Free Cash Flow | -$1.5M | -449.6% |
| -2977.3% |
| EPS (Basic) | -$2.07 | -2400.0% |